Beclomethasone Dipropionate; Formoterol Fumarate; Glycopyrrolate Patent Expiration

Beclomethasone Dipropionate; Formoterol Fumarate; Glycopyrrolate was first introduced by Chiesi Farmaceutici Spa in its drug Trimbow on May 14, 2026.


Beclomethasone Dipropionate; Formoterol Fumarate; Glycopyrrolate Patents

Given below is the list of patents protecting Beclomethasone Dipropionate; Formoterol Fumarate; Glycopyrrolate, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

NEW
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Trimbow US10617638 Stable Pressurized Aerosol Solution Composition Of Glycopyrronium Bromide And Formoterol Combination Dec 23, 2034 Chiesi
Trimbow US10159645 Combination Therapy For Copd Dec 23, 2030 Chiesi
Trimbow US10806701 Aerosol Formulation For Copd Dec 23, 2030 Chiesi
Trimbow US11389401 Combination Therapy For Copd Dec 23, 2030 Chiesi
Trimbow US11590074 Aerosol Formulation For Copd Dec 23, 2030 Chiesi
Trimbow US12357568 Aerosol Formulation For Copd Dec 23, 2030 Chiesi



Beclomethasone Dipropionate; Formoterol Fumarate; Glycopyrrolate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Beclomethasone Dipropionate; Formoterol Fumarate; Glycopyrrolate Generic API Manufacturers

Given below is the list of companies who have filed for Beclomethasone Dipropionate; Formoterol Fumarate; Glycopyrrolate generic, along with the locations of their manufacturing plants worldwide.